Dr Christos Toumpanakis, Gastroenterologist
Dr Christos Toumpanakis
Gastroenterologist
Dr Christos Toumpanakis
Gastroenterologist
Dr Christos Toumpanakis
Gastroenterologist
About Dr Christos Toumpanakis
GMC number: 6121373
Year qualified: 1994
Place of primary qualification: National Capodistrian University of Athens
Dr Christos Toumpanakis is a highly accomplished consultant in gastroenterology and neuroendocrine tumours (NET) at the Neuroendocrine Tumour Unit of Royal Free Hospital in London, UK, since 2007. He is also an honorary associate professor at University College London (UCL) and has been awarded "Top-Teacher of the Year" seven times.
Dr Toumpanakis graduated from the Medical School at the University of Athens, Greece, in 1994. He obtained his specialty title in gastroenterology and hepatology in 2004 and completed his PhD at the University of Athens in 2007. He is globally recognised as a leading expert in NET and has been involved in this area since 2000.
Dr Toumpanakis is a regular lecturer at several national and international conferences and has published more than 100 original papers and reviews on the subject. He serves as the chair of the advisory board of the European Neuroendocrine Tumour Society (ENETS), co-chair of the post-graduate course of the ENETS annual conference, and co-editor of the ENETS CME programme. Additionally, he is a co-author of the UK and Ireland NET Society and European NET Society guidelines, an associate editor of the "Journal of Neuroendocrinology", and a member of the advisory board of the "UK NET Patients' Foundation".
Dr Toumpanakis leads a NET clinical research group, involving junior doctors and UCL medical students in NET clinical research projects. His main research interests include novel NET biomarkers, molecular imaging in NETs, and carcinoid heart disease. He organised the first international conference for "Carcinoid Heart Disease" in London in 2014, which led to the development of an international network of experts who published the first-ever international management guidelines for carcinoid heart disease in March 2017.
Apart from NET, Dr Toumpanakis sees patients with all general gastrointestinal conditions, including gastro-oesophageal reflux disease, coeliac disease, chronic diarrhoea, inflammatory bowel disease, and gastrointestinal problems in patients with congenital immuno-deficiencies.